RESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Preescolar , Hiperqueratosis Epidermolítica/diagnóstico , Hiperqueratosis Epidermolítica/patología , Dermoscopía , Hipopigmentación/diagnóstico por imagen , Enfermedades Cutáneas Papuloescamosas/patología , Papulosis Linfomatoide/diagnóstico , Proteínas Activadoras de Esfingolípidos/análisis , Hipopigmentación/patología , Diagnóstico Diferencial , Inmunohistoquímica , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patologíaRESUMEN
Gangliosides (GGs) are sialic acid-containing glycosphingolipids (GSLs) and major membrane components enriched on cellular surfaces. Biosynthesis of mammalian GGs starts at the cytosolic leaflet of endoplasmic reticulum (ER) membranes with the formation of their hydrophobic ceramide anchors. After intracellular ceramide transfer to Golgi and trans-Golgi network (TGN) membranes, anabolism of GGs, as well as of other GSLs, is catalyzed by membrane-spanning glycosyltransferases (GTs) along the secretory pathway. Combined activity of only a few promiscuous GTs allows for the formation of cell-type-specific glycolipid patterns. Following an exocytotic vesicle flow to the cellular plasma membranes, GGs can be modified by metabolic reactions at or near the cellular surface. For degradation, GGs are endocytosed to reach late endosomes and lysosomes. Whereas membrane-spanning enzymes of the secretory pathway catalyze GSL and GG formation, a cooperation of soluble glycosidases, lipases and lipid-binding cofactors, namely the sphingolipid activator proteins (SAPs), act as the main players of GG and GSL catabolism at intralysosomal luminal vesicles (ILVs).
Asunto(s)
Ceramidas/metabolismo , Retículo Endoplásmico/metabolismo , Gangliósidos/metabolismo , Lisosomas/metabolismo , Animales , Secuencia de Carbohidratos , Gangliósidos/química , Glicosiltransferasas/metabolismo , Humanos , Proteínas Activadoras de Esfingolípidos/metabolismo , Red trans-Golgi/metabolismoRESUMEN
Background. Mucinous gastrointestinal cancers may indicate a higher propensity for widespread peritoneal seeding than their non-mucinous counterparts. We hypothesized that mucin content of gastrointestinal cancer cells and tumors is an indicator of cell viability and a determinant of the peritoneal tumor burden and tested our hypothesis in relevant experimental models. Methods. MKN45 and LS174T models of human gastrointestinal cancer were treated with known mucin-depleting agents in vitro and in vivo, their mucin production was evaluated with Western blot immunohistochemistry, PAS staining and ELISA, and its correlation with cell viability and peritoneal tumor burden was analyzed. Results. A relationship was found between the viability of cancer cells and their mucin levels in vitro. In agreement, when treated animal models were categorized into low- and high-burden groups (based on the weight and number of the peritoneal nodules), tumoral mucin levels were found to be significantly higher in the latter group. Conclusions. Tumoral mucin is apparently among the factors that dictate the pattern and extent of the peritoneal spread of gastrointestinal cancer, where it allows for enhanced dissemination and redistribution. If further tested and validated, our hypothesis could lay the basis for the development of novel mucin-targeted strategies (AU)
No disponible
Asunto(s)
Animales , Masculino , Femenino , Neoplasias Gastrointestinales/diagnóstico , Neoplasias Peritoneales/complicaciones , Mucina-1/administración & dosificación , Mucinas Gástricas/administración & dosificación , Mucinas Gástricas/análisis , Mucina 2/administración & dosificación , Mucina 2/análisis , Mucina 5AC/administración & dosificación , Mucina 5AC/análisis , Modelos Animales , Inmunohistoquímica/métodos , Inmunohistoquímica/normas , Inmunohistoquímica , Western Blotting/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Proteínas Activadoras de Esfingolípidos/análisisRESUMEN
Glycosphingolipids and sphingolipids of cellular plasma membranes (PMs) reach luminal intra-lysosomal vesicles (LVs) for degradation mainly by pathways of endocytosis. After a sorting and maturation process (e.g. degradation of sphingomyelin (SM) and secretion of cholesterol), sphingolipids of the LVs are digested by soluble enzymes with the help of activator (lipid binding and transfer) proteins. Inherited defects of lipid-cleaving enzymes and lipid binding and transfer proteins cause manifold and fatal, often neurodegenerative diseases. The review summarizes recent findings on the regulation of sphingolipid catabolism and cholesterol secretion from the endosomal compartment by lipid modifiers, an essential stimulation by anionic membrane lipids and an inhibition of crucial steps by cholesterol and SM. Reconstitution experiments in the presence of all proteins needed, hydrolase and activator proteins, reveal an up to 10-fold increase of ganglioside catabolism just by the incorporation of anionic lipids into the ganglioside carrying membranes, whereas an additional incorporation of cholesterol inhibits GM2 catabolism substantially. It is suggested that lipid and other low molecular modifiers affect the genotype-phenotype relationship observed in patients with lysosomal diseases.
Asunto(s)
Lisosomas/metabolismo , Lípidos de la Membrana/metabolismo , Proteínas Activadoras de Esfingolípidos/metabolismo , Esfingolipidosis/metabolismo , Esfingolípidos/metabolismo , Colesterol/metabolismo , Endosomas/metabolismo , Humanos , Modelos BiológicosRESUMEN
Background. Onychomycosis is the most common nail disease and represents around 50% of nail disorders. Accurate diagnosis with adequate evidence is ideal before starting any treatment. Current diagnostic methods offer low specificity and sensitivity. Aims. To create a new method for the diagnosis of onychomycosis, and to compare its sensitivity and specificity with the existing methods. Methods. One hundred and ninety-two samples with clinical suspicion of onychomycosis were included and underwent modified PAS stain (M-PAS), KOH/chlorazol black (KOH/CB) and culture testing. Sensitivity, specificity, positive and negative predictive values were calculated. Results. In 152 out of 192 samples (79.2%) fungi structures were found in at least one of the three tests performed, and the patients were diagnosed with onychomycosis; 40 samples out of 192 (20.8%) were negative. Using M-PAS, filaments and/or spores were seen in 143 samples from the 152 positive (94%); 39 of them were negative to KOH/CB and positive to M-PAS (25.6%). With KOH/CB, filaments and/or spores were seen in 113 cases from the 152 positive samples (73.8% of the onychomycosis cases). Thirty-five cultures were positive, of which 77% were identified as Trichophyton rubrum; 117 onychomycosis cases were diagnosed despite the negative culture (76.9%). M-PAS showed 92.5% sensitivity and 55.55% specificity, a 67.5% positive predictive value and a 81.6% negative productive value. Conclusions. This procedure, a combination of the existing methods to diagnose onychomycosis, KOH/CB together with a nail clipping biopsy, proved to have high sensitivity, as well as being rapid, easy, inexpensive and readily available in most hospital settings. M-PAS allowed us to diagnose 39 cases (25.6% of the cases of onychomycosis) that were false negative using only KOH/CB and culture (AU)
Antecedentes. La onicomicosis es la enfermedad más común de las uñas y representa un 50% del total de las enfermedades que afectan a esta parte del cuerpo. Antes de iniciar un tratamiento, es muy recomendable contar con un diagnóstico preciso y pruebas suficientes. En la actualidad, los métodos diagnósticos ofrecen una sensibilidad y especificidad bajas. Objetivos. Crear un nuevo método de diagnóstico de la onicomicosis y comparar su sensibilidad y especificidad con los métodos diagnósticos existentes. Métodos. Se recogieron ciento noventa y dos muestras con sospecha clínica de onicomicosis en las que se aplicaron las pruebas de examen directo con KOH/Negro de clorazol (KOH/CB), cultivo y examen directo teñido con PAS (M-PAS). Se calcularon la sensibilidad, la especificidad, y los valores predictivos positivo y negativo. Resultados. En 152 de las 192 muestras (79,2%) se hallaron estructuras micóticas en una de las tres pruebas realizadas como mínimo, y se diagnosticó onicomicosis en dichos pacientes; 40 de las 192 muestras (20,8%) dieron resultados negativos. Mediante M-PAS, se observaron filamentos o esporas en 143 de las 152 muestras (94%); 39 de ellas resultaron negativas con KOH/CB y positivas con M-PAS (25,6%). En el caso de KOH/CB, se observaron filamentos o esporas en 113 de las 152 muestras, (73,8% de los casos de onicomicosis). Treinta y cinco cultivos dieron resultados positivos, conel 77% de los aislamientos obtenidos identificados como Trichophyton rubrum; se diagnosticaron 117 casos de onicomicosis a pesar de los resultados negativos en el cultivo (76,9%). La sensibilidad de M-PAS fue del 92,5%, la especificidad del 55,55%, y los valores predictivos positivo y negativo de 67,5% y 81,6%, respectivamente. Conclusiones. Este procedimiento, una fusión de métodos ya existentes para el diagnóstico de la onicomicosis, que aplica KOH/CB junto con una biopsia de fragmentos de uña, mostró una gran sensibilidad. Es además un método rápido, fácil, económico y disponible en la mayoría de los ámbitos hospitalarios. M-PAS permitió diagnosticar 39 casos (25,6% de los pacientes con onicomicosis) con resultados falsos negativos al utilizar únicamente KOH/CB y cultivo (AU)
Asunto(s)
Humanos , Masculino , Femenino , Onicomicosis/diagnóstico , Onicomicosis/microbiología , Onicomicosis/patología , Proteínas Activadoras de Esfingolípidos , Sensibilidad y Especificidad , Valor Predictivo de las Pruebas , Trichophyton/aislamiento & purificación , Micología/métodos , Trichophyton/patogenicidad , Técnicas Microbiológicas/métodos , Técnicas MicrobiológicasAsunto(s)
Aciltransferasas/metabolismo , Enzimas Multifuncionales/biosíntesis , Serina C-Palmitoiltransferasa/metabolismo , Proteínas Activadoras de Esfingolípidos/biosíntesis , Proteínas Activadoras de Esfingolípidos/química , Animales , Humanos , Mutación/fisiología , Especificidad por Sustrato/fisiologíaRESUMEN
OBJECTIVE: To observe the one-year neurologic prognostic outcome of newborns with moderate and severe hypoxic-ischemic encephalopathy (HIE) who received recombinant human erythropoietin (rhuEPO) combined with exogenous monosialotetrahexosylganglioside (GM1) treatment to provide new guidelines for clinical treatment. PATIENTS AND METHODS: Seventy-six newborns with moderate and severe HIE were selected from February 2011 to February 2014 in our hospital. This study received the informed consent of our hospital's Ethics Committee and the newborns' guardians. The newborns were divided to an observation group (n = 34 cases) and a control group (n = 42 cases). All newborns underwent hypothermia and conventional treatment for their conditions. The control group received GMl treatment and observation group received rhuEPO combined with GMl treatment. The curative differences and neural behavior from these two groups were compared. RESULTS: The excellent, efficient proportion and total effective rate of the newborns from the observation group were higher than the control group. The death rate, cerebral palsy and the invalid ratio of the newborns from the observation group were lower than that of the control group. Awareness, muscle tension, primitive reflex and increased intracranial pressure recovery time of the newborns in the observation group were less than those of the control group. The Neonatal Behavior Neurological Assessment (NBNA) score of both groups after the treatment of 7, 14 and 28 days were significantly higher and increased with time (p < 0.05). The MDI, PDI and DQ score of newborns from the two groups all increased after treatment of 3, 6 and 12 months than those of before, which increased with time (p < 0.05). CONCLUSIONS: The rhuEPO + GMl treatment in newborns with HIE improves short-term clinical effects and long-term neurological symptoms.
Asunto(s)
Eritropoyetina/administración & dosificación , Hipoxia-Isquemia Encefálica/diagnóstico , Hipoxia-Isquemia Encefálica/tratamiento farmacológico , Proteínas Recombinantes/administración & dosificación , Índice de Severidad de la Enfermedad , Proteínas Activadoras de Esfingolípidos/administración & dosificación , Parálisis Cerebral/diagnóstico , Parálisis Cerebral/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Humanos , Recién Nacido , Masculino , Examen Neurológico/métodos , Pronóstico , Resultado del TratamientoRESUMEN
Endocytosed (glyco)sphingolipids are degraded, together with other membrane lipids in a stepwise fashion by endolysosomal enzymes with the help of small lipid binding proteins, the sphingolipid activator proteins (SAPs), at the surface of intraluminal lysosomal vesicles. Inherited defects in a sphingolipid-degrading enzyme or SAP cause the accumulation of the corresponding lipid substrates, including cytotoxic lysosphingolipids, such as galactosylsphingosine and glucosylsphingosine, and lead to a sphingolipidosis. Analysis of patients with prosaposin deficiency revealed the accumulation of intra-endolysosmal vesicles and membrane structures (IM). Feeding of prosaposin reverses the storage, suggesting inner membrane structures as platforms of sphingolipid degradation. Water soluble enzymes can hardly attack sphingolipids embedded in the membrane of inner endolysosomal vesicles. The degradation of sphingolipids with few sugar residues therefore requires the help of the SAPs, and is strongly stimulated by anionic membrane lipids. IMs are rich in anionic bis(monoacylglycero)phosphate (BMP). This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biology.
Asunto(s)
Enfermedades por Almacenamiento Lisosomal/metabolismo , Enfermedades por Almacenamiento Lisosomal/patología , Lisosomas/metabolismo , Lisosomas/patología , Esfingolípidos/metabolismo , Animales , Humanos , Proteínas Activadoras de Esfingolípidos/metabolismoRESUMEN
Cadherins are essential in many fundamental processes and assemble at regions of cell-cell contact in large macromolecular complexes named adherens junctions. We have identified flotillin 1 and 2 as new partners of the cadherin complexes. We show that flotillins are localised at cell-cell junctions (CCJs) in a cadherin-dependent manner. Flotillins and cadherins are constitutively associated at the plasma membrane and their colocalisation at CCJ increases with CCJ maturation. Using three-dimensional structured illumination super-resolution microscopy, we found that cadherin and flotillin complexes are associated with F-actin bundles at CCJs. The knockdown of flotillins dramatically affected N- and E-cadherin recruitment at CCJs in mesenchymal and epithelial cell types and perturbed CCJ integrity and functionality. Moreover, we determined that flotillins are required for cadherin association with GM1-containing plasma membrane microdomains. This allows p120 catenin binding to the cadherin complex and its stabilization at CCJs. Altogether, these data demonstrate that flotillin microdomains are required for cadherin stabilization at CCJs and for the formation of functional CCJs.
Asunto(s)
Cadherinas/metabolismo , Uniones Intercelulares/genética , Proteínas de la Membrana/metabolismo , Cadherinas/genética , Cateninas/metabolismo , Membrana Celular/metabolismo , Técnicas de Silenciamiento del Gen , Células HCT116 , Humanos , Uniones Intercelulares/metabolismo , Células MCF-7 , Proteínas de la Membrana/genética , Estructura Terciaria de Proteína , Proteínas Activadoras de Esfingolípidos/metabolismo , Catenina deltaRESUMEN
Hepatitis B is considered to be a worldwide public health problem. An immunosuppressor microenvironment has been proposed to contribute to viral persistence during chronic disease. Understanding the intracellular signaling cascade in T-cells from HBV-infected patients, will contribute to unravel the mechanisms that control the development of immune response during hepatitis B. We analyze lipid rafts formation and early activation signals in chronic HBV infected patients, compared to naturally immune subjects (NIS). Patients show: (1) diminished GM1 clustering, (2) A deficient lipid rafts recruitment of CD3ζ/ZAP-70/Grb2, and (3) these proteins do not merge with GM1 within the lipid rafts. Finally, immunoprecipitation assays proved that ZAP-70 does not associate to CD3ζ. These results show for the first time, defects regarding early key events in T-cell activation, in chronically infected HBV patients, which may contribute not only to understand HBV immune tolerance, but to reveal new potential therapeutic targets to control the infection.
Asunto(s)
Complejo CD3/inmunología , Proteína Adaptadora GRB2/inmunología , Virus de la Hepatitis B/inmunología , Hepatitis B Crónica/inmunología , Microdominios de Membrana/inmunología , Linfocitos T/inmunología , Proteína Tirosina Quinasa ZAP-70/inmunología , Inmunidad Adaptativa , Complejo CD3/metabolismo , Citometría de Flujo , Proteína Adaptadora GRB2/metabolismo , Hepatitis B Crónica/metabolismo , Hepatitis B Crónica/virología , Humanos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Microdominios de Membrana/metabolismo , Microscopía Fluorescente , ARN Viral/química , ARN Viral/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas Activadoras de Esfingolípidos/inmunología , Linfocitos T/metabolismo , Proteína Tirosina Quinasa ZAP-70/metabolismoRESUMEN
Analysis of lipid storage in postmortem brains of patients with amaurotic idiocy led to the recognition of five lysosomal ganglioside storage diseases and identification of their inherited metabolic blocks. Purification of lysosomal acid sphingomyelinase and ceramidase and analysis of their gene structures were the prerequisites for the clarification of Niemann-Pick and Farber disease. For lipid catabolism, intraendosomal vesicles are formed during the endocytotic pathway. They are subjected to lipid sorting processes and were identified as luminal platforms for cellular lipid and membrane degradation. Lipid binding glycoproteins solubilize lipids from these cholesterol poor membranes and present them to water-soluble hydrolases for digestion. Biosynthesis and intracellular trafficking of lysosomal hydrolases (hexosaminidases, acid sphingomyelinase and ceramidase) and lipid binding and transfer proteins (GM2 activator, saposins) were analyzed to identify the molecular and metabolic basis of several sphingolipidoses. Studies on the biosynthesis of glycosphingolipids yielded the scheme of Combinatorial Ganglioside Biosynthesis involving promiscuous glycosyltransferases. Their defects in mutagenized mice impair brain development and function.
Asunto(s)
Esfingolipidosis/metabolismo , Esfingolípidos/metabolismo , Animales , Encéfalo/metabolismo , Encéfalo/patología , Endocitosis , Humanos , Lisosomas/enzimología , Lisosomas/metabolismo , Proteínas Activadoras de Esfingolípidos/química , Proteínas Activadoras de Esfingolípidos/metabolismo , Esfingolipidosis/enzimología , Esfingolipidosis/genética , Esfingolipidosis/patología , Esfingolípidos/biosíntesisRESUMEN
Serum antibodies to different gangliosides have been identified in some Guillain-Barré (GBS) subtypes and variants. In the January issue of Experimental Neurology Susuki and colleagues (2012) showed that in experimental neuropathies associated with antibodies to GM1, GD1a and GD1b the common mechanism is a complement mediated dysfunction and disruption of the nodes of Ranvier which causes a pathophysiological continuum from early reversible conduction failure to axonal degeneration. These observations, correlated and integrated with electrophysiological and pathological findings in humans indicate that the GBS subtypes acute motor conduction block neuropathy, acute motor axonal neuropathy, acute motor and sensory neuropathy and acute sensory neuropathy and possibly also a chronic disorder as multifocal motor neuropathy represent a spectrum of the same immunopathologic process. Being the nodal axolemma and the paranode the focus of the nerve injury, these immune mediated neuropathies could be more properly classified as nodo-paranodopathies.
Asunto(s)
Autoanticuerpos/fisiología , Gangliósidos/inmunología , Polineuropatías/clasificación , Polineuropatías/inmunología , Animales , Autoanticuerpos/clasificación , Síndrome de Guillain-Barré/clasificación , Síndrome de Guillain-Barré/inmunología , Síndrome de Guillain-Barré/metabolismo , Humanos , Polineuropatías/metabolismo , Proteínas Activadoras de Esfingolípidos/inmunologíaRESUMEN
Mutated PSAP gene resulting in sphingolipid activator protein B deficiency is known to cause metachromatic leukodystrophy variant in which arylsulfatase A is normal. Of 16 patients with metachromatic leukodystrophy that were evaluated in our center, 7 patients were diagnosed with arylsulfatase A-deficient metachromatic leukodystrophy, whereas 9 children from 4 unrelated Saudi families were found to have sphingolipid activator protein B deficiency. PSAP analysis found that the 4 families segregate the same homozygous mutation that was a g.722G>C transversion resulting in C241S change, which was previously reported in an Arab patient. Our work, which reports the largest series of patients with sphingolipid activator protein B deficiency, suggests that this variant is likely to be more common than arylsulfatase A-deficient metachromatic leukodystrophy in Arabs, a notion that has potential diagnostic and preventive implications.
Asunto(s)
Predisposición Genética a la Enfermedad/genética , Leucodistrofia Metacromática/genética , Leucodistrofia Metacromática/metabolismo , Mutación/genética , Proteínas Activadoras de Esfingolípidos/deficiencia , Proteínas Activadoras de Esfingolípidos/genética , Sustitución de Aminoácidos/genética , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/fisiopatología , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Marcadores Genéticos/genética , Pruebas Genéticas , Genotipo , Humanos , Lactante , Leucodistrofia Metacromática/fisiopatología , Masculino , Arabia SauditaRESUMEN
Prosaposin, a 66 kDa glycoprotein, was identified initially as the precursor of the sphingolipid activator proteins, saposins A-D, which are required for the enzymatic hydrolysis of certain sphingolipids by lysosomal hydrolases. While mature saposins are distributed to lysosomes, prosaposin exists in secretory body fluids and plasma membranes. In addition to its role as the precursor, prosaposin shows a variety of neurotrophic and myelinotrophic activities through a receptor-mediated mechanism. In studies in vivo, prosaposin was demonstrated to exert a variety of neuro-efficacies capable of preventing neuro-degeneration following neuro-injury and promoting the amelioration of allodynia and hyperalgesia in pain models. Collective findings indicate that prosaposin is not a simple house-keeping precursor protein; instead, it is a protein essentially required for the development and maintenance of the central and peripheral nervous systems. Accumulating evidence over the last decade has attracted interests in exploring and developing new therapeutic approaches using prosaposin for human disorders associated with neuro-degeneration. In this review we detail the structure characteristics, cell biological feature, in vivo efficacy, and neuro-therapeutic potential of prosaposin, thereby providing future prospective in clinical application of this multifunctional protein.
Asunto(s)
Bioquímica , Transporte Biológico/fisiología , Glicoproteínas/uso terapéutico , Neurobiología , Sistema Nervioso Periférico/fisiología , Precursores de Proteínas/metabolismo , Saposinas/fisiología , Proteínas Activadoras de Esfingolípidos/uso terapéutico , Empalme Alternativo/genética , Secuencia de Aminoácidos , Secuencia Conservada/genética , Secuencia Conservada/fisiología , Femenino , Humanos , Lactancia/metabolismo , Metabolismo de los Lípidos/fisiología , Datos de Secuencia Molecular , Factores de Crecimiento Nervioso/fisiología , Precursores de Proteínas/genética , Saposinas/genética , Saposinas/metabolismo , Proteínas Activadoras de Esfingolípidos/metabolismo , Distribución Tisular/fisiología , TransfecciónRESUMEN
The delivery of soluble lysosomal proteins to the lysosomes is dependent primarily on the mannose 6-phosphate receptor (MPR). The MPR has been demonstrated to attain the early endosomes via a process that requires the interaction of its cytosolic domain with the GGA and AP-1 adaptor proteins. Additionally, the MPR can be recycled back to the trans-Golgi network (TGN) through its interaction with the retromer complex. Interestingly, in I-cell disease (ICD), in which the MPR pathway is non-functional, many soluble lysosomal proteins continue to traffic to the lysosomes. This observation led to the discovery that sortilin is responsible for the MPR-independent targeting of the sphingolipid activator proteins (SAPs) and acid sphingomyelinase (ASM). More recently, our laboratory has tested the hypothesis that sortilin is also capable of sorting a variety of cathepsins that exhibit varying degrees of MPR-independent transport. We have demonstrated that the transport of cathepsin D is partially dependent upon sortilin, that cathepsin H requires sortilin, and that cathepsins K and L attain the lysosomes in a sortilin-independent fashion. As a type-1 receptor, sortilin also has numerous cytosolic binding partners. It has been observed that like the MPR, the anterograde trafficking of sortilin and its cargo require both GGAs and AP-1. Similarly, the retrograde recycling pathway of sortilin also involves an interaction with retromer through a YXXphi site in the cytosolic tail of sortilin. In conclusion, the cytosolic domains of sortilin and MPR possess a high degree of functional homology and both receptors share a conserved trafficking mechanism.
Asunto(s)
Proteínas Adaptadoras del Transporte Vesicular/fisiología , Lisosomas/metabolismo , Factores de Ribosilacion-ADP/metabolismo , Complejo 1 de Proteína Adaptadora/metabolismo , Proteínas Adaptadoras del Transporte Vesicular/metabolismo , Animales , Catepsina D/metabolismo , Catepsina H , Catepsina K , Catepsina L , Catepsinas/metabolismo , Cisteína Endopeptidasas/metabolismo , Humanos , Hidrolasas/metabolismo , Mucolipidosis/metabolismo , Estructura Terciaria de Proteína , Transporte de Proteínas , Receptor IGF Tipo 2/fisiología , Proteínas Activadoras de Esfingolípidos/metabolismo , Red trans-Golgi/metabolismoRESUMEN
The neuronal ceroid lipofuscinoses (NCLs) are autosomal recessively inherited disorders collectively considered to be one among the most common pediatric neurodegenerative lysosomal storage diseases. Four main clinical subtypes have been described based on the age at presentation: infantile, late infantile, juvenile and adult types. In addition, rare congenital cases of NCL have been reported in the literature. Previously, a homozygous mutation in the cathepsin D gene has been shown to cause congenital NCL in a patient of Pakistani origin. We report a case of a 39-week estimated gestational age female infant with severe microcephaly and hypertonia, whereas MRI showed generalized hypoplasia of the cerebral and cerebellar hemispheres. The infant died on day two after birth. Postmortem examination revealed a small, firm brain with extensive neuronal loss and gliosis. Remaining neurons, astrocytes and macrophages contained PAS-positive storage material with granular ultrastructure and immunoreactivity against sphingolipid activator protein D. A diagnosis of congenital NCL was rendered with a novel mutation, c.299C > T (p.Ser100Phe) in exon 3 of the cathepsin D gene. In the patient fibroblasts, cathepsin D activity was marginal, but the protein appeared stable and normally processed. This was confirmed in overexpression studies. Importantly, by identification of the mutation in the family, we were able to confirm the first prenatal diagnosis excluding cathepsin D deficiency in the younger sibling of the patient.
Asunto(s)
Catepsina D/deficiencia , Catepsina D/genética , Muestra de la Vellosidad Coriónica , Lipofuscinosis Ceroideas Neuronales/genética , Adulto , Astrocitos/química , Astrocitos/ultraestructura , Encéfalo/patología , Química Encefálica , Muerte Celular , Femenino , Fibroblastos/enzimología , Gliosis/genética , Gliosis/patología , Humanos , Recién Nacido , Macrófagos/química , Macrófagos/ultraestructura , Microcefalia/genética , Hipertonía Muscular/genética , Lipofuscinosis Ceroideas Neuronales/diagnóstico , Lipofuscinosis Ceroideas Neuronales/enzimología , Lipofuscinosis Ceroideas Neuronales/patología , Neuronas/ultraestructura , Mutación Puntual , Embarazo , Proteínas Activadoras de Esfingolípidos/análisisRESUMEN
Cellular membranes contain microdomains known as 'lipid rafts' or detergent-insoluble microdomains (DRM), enriched in cholesterol and sphingolipids. DRM can play an important role in many cellular processes, including signal transduction, cytoskeletal organization, and pathogen entry. Many receptors like T cell receptors, B cell receptors and IgE receptors have been shown to reside in DRM. The majority of these receptors depend on multivalent ligand interaction to associate with these microdomains. We, here, study association between the high affinity IgG receptor, FcgammaRI (CD64), and membrane microdomains. FcgammaRI is a 72kDa type I glycoprotein that can mediate phagocytosis of opsonized pathogens, but can also effectively capture small immune complexes, and facilitates antigen presentation. We found FcgammaRI to predominantly reside within detergent-insoluble buoyant membranes, together with FcRgamma-chain, but independent of cross-linking ligand. With the use of confocal imaging, FcgammaRI was found to co-patch with GM1, a microdomain-enriched glycolipid. Depletion of cellular cholesterol, furthermore, modulated FcgammaRI-ligand interactions. These data indicated FcgammaRI to reside within lipid rafts without prior triggering of the receptor.
Asunto(s)
Microdominios de Membrana/química , Microdominios de Membrana/metabolismo , Receptores de IgG/metabolismo , Animales , Línea Celular , Células Cultivadas , Colesterol/deficiencia , Colesterol/metabolismo , Humanos , Leucocitos Mononucleares/química , Leucocitos Mononucleares/citología , Ratones , Receptores de IgG/química , Receptores de IgG/genética , Proteínas Activadoras de Esfingolípidos/inmunologíaRESUMEN
Niemann-Pick type C disease is an inherited fatal disorder characterized by the accumulation of unesterified cholesterol and other lipids in the endosomal/lysosomal compartment. Two independent genes responsible for this neurodegenerative disorder have been identified, but the precise functions of the encoded Niemann-Pick C1 (NPC1) and C2 (NPC2) proteins are not yet known. We developed a cell-free assay for measuring intermembrane lipid transport and examined the ability of bovine NPC2 (bNPC2) for intermembrane cholesterol transfer. NPC2 specifically extracts cholesterol from phospholipid bilayers and catalyzes intermembrane transfer to acceptor vesicles in a dose- and time-dependent manner. This transfer activity is dependent on temperature, pH, ionic strength, lipid composition of the model membranes, and the ratio of donor to acceptor vesicles. In model membranes, the presence of the lysosomal anionic phospholipids bis(monooleoylglycero)phosphate and phosphatidyl inositol significantly stimulated cholesterol transfer by NPC2, whereas bis(monomyristoylglycero)phosphate, phosphatidyl serine, and phosphatidic acid had no effect. Moreover, ceramide stimulated cholesterol transfer slightly, whereas sphingomyelin reduced cholesterol transfer rates. With our assay system we identified for the first time the ability of other lysosomal proteins, most notably the GM2-activator protein, to mediate intermembrane cholesterol transfer. This assay system promises to be a valuable tool for further quantitative and mechanistic studies of protein-mediated lipid transfer.
Asunto(s)
Bioensayo , Proteínas Portadoras/metabolismo , Colesterol/metabolismo , Glicoproteínas/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Bovinos , Ceramidas/farmacología , Humanos , Liposomas/metabolismo , Lisofosfolípidos/farmacología , Monoglicéridos/farmacología , Palmitatos/farmacología , Ácidos Fosfatidicos/farmacología , Fosfatidilserinas/farmacología , Proteínas Activadoras de Esfingolípidos/metabolismo , Esfingomielinas/farmacología , Vesículas Transportadoras/metabolismo , Proteínas de Transporte VesicularRESUMEN
Monocytes constitute 5-10% of total human peripheral blood leucocytes and remain in circulation for several days before replenishing the tissue macrophage populations. Monocytes display heterogeneity in size, granularity and nuclear morphology, and in the expression of cell membrane molecules, such as CD14, CD16, CD32, CD64, major histocompatibility complex class II, CCR2, CCR5, among others. This has led to the suggestion that individual monocyte/macrophage populations have specialized functions within their microenvironments. This study provides evidence for the occurrence of two peripheral blood monocyte subpopulations on the basis of their differential expression of GM1, a sphingolipid found mostly in lipid rafts, a CD14(+) GM1(low) population and a CD14(+) GM1(high) population comprising about 97.5% and 2.5% of total CD14(+) cells, respectively. GM1 expression correlates with functional differences in terms of endocytic activity, susceptibility to mycobacterial infection, and response to lipopolysaccharide (LPS) (modulation of Toll-like receptor-4 expression). CD14(+) GM1(low) cells proved to be less endocytic and more responsive to LPS, whereas CD14(+) GM1(high) cells are more endocytic and less responsive to LPS. In addition, during monocyte to macrophage differentiation in vitro, the percentage of CD14(+) GM1(high) cells increases from about 2.5% at day 1 to more than 50% at day 7 of culture. These results suggest that GM1(low) and GM1(high) monocytes in peripheral blood, represent either different stages of maturation or different subsets with specialized activities. The expression of CD16 on GM1(high) favours the first possibility and, on the other hand that up-regulation of GM1 expression and probably lipid rafts function is involved in the monocyte to macrophage differentiation process.
Asunto(s)
Endocitosis , Microdominios de Membrana/metabolismo , Monocitos/metabolismo , Proteínas Activadoras de Esfingolípidos/sangre , Diferenciación Celular/inmunología , Células Cultivadas , Susceptibilidad a Enfermedades , Humanos , Receptores de Lipopolisacáridos , Lipopolisacáridos/farmacología , Macrófagos/inmunología , Monocitos/inmunología , Monocitos/fisiología , Mycobacterium bovis , Proteínas Activadoras de Esfingolípidos/inmunología , Receptor Toll-Like 4/sangre , Tuberculosis/inmunologíaRESUMEN
Synapse loss in Alzheimer's disease (AD) is poorly understood but evidence suggests it is a key pathological event. In order to precisely detect stable synaptic changes, we have developed methods for flow cytometry analysis of synaptosomes prepared from cryopreserved AD samples, and have previously shown that amyloid-beta (Abeta) accumulates in surviving presynaptic terminals in AD cortex. In the present experiments we have examined amyloid-containing terminals in more detail, first dual labeling synaptosomes from AD cortex for Abeta and a series of markers, and then using quadrant analysis to compare amyloid-positive and amyloid-negative terminals. Amyloid-positive synaptosomes were larger in size than amyloid-negatives (p<0.007), and significant increases were observed in mean fluorescence for the lipid raft markers cholesterol (27%; p<0.0005) and GM1 ganglioside (24%; p<0.005). SNAP-25 immunofluorescence was increased by 31% (p<0.0001) in amyloid-bearing terminals, consistent with a sprouting response to amyloid accumulation. These results suggest that Abeta accumulation in synaptic terminals may underly dysfunction prior to or independent of extracellular amyloid deposition.